Results 121 to 130 of about 13,923 (166)

Advances in cancer vaccines for immunotherapy of prostate cancer. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023
Jin T, Zhou C, Zhao L, Dong X, Zhou F.
europepmc   +1 more source

重组干扰素治疗慢性丙型肝炎的临床及肝组织学疗效评价

Zhongshan Daxue xuebao. Yixue kexue ban, 1994
报告８４例慢性丙型肝炎（ＣＨＣ）患者，通过临床、血清学、肝组织学、分子生物学和免疫组织化学等方法，观察应用重组α－干扰素加传统护肝治疗的效果，疗程２４周，并与单用传统护肝治疗的对照组治疗前后各项指标变化比较。疗程结束时结果显示：治疗组６４例中，血清ＡＬＴ复常率为７０．３％，ＨＣＶ－ＲＮＡ阴转率为６７．２％，肝组织学好转率为６５．６％，肝组织内ＨＣＶ－ＲＮＡ阴转率为５１．５％，肝组织内ＨＣＶ－Ａｇ抗原的免疫组化检出率从治疗前的１５．６％减至治疗后的６．３％，分别显著高于对照组（Ｐ＜０．０５ ...
doaj  

[Chinese expert consensus on the evaluation of allergen-specific immunotherapy outcomes（Wuhan, 2025）]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Deng Y, Luo X, Liu Z, Sun S, Ye J, Wang T, Chen J, Lu M, Yao Y, Wang Y, Zhou W, Liu B, Zeng Q, Xu Y, Yang Q, Yang Y, Liu F, Xu C, Sun Y, Hong H, Ye H, Zhang L, Chen F, Li H, Wang H, Li Y, Liu W, Xu Y, Lou H.   +28 more
europepmc   +1 more source

New characteristics of cancer immunotherapy: trends in viral tumor immunotherapy with influenza virus-based approaches. [PDF]

J Zhejiang Univ Sci B
Hu S, Cai Y, Shen Y, Shao Y, DU Y, Chen Y.   +5 more
europepmc   +1 more source

[Current status and progress of health economics research on allergen specific immunotherapy]. [PDF]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Hu Q, Li L, Long Z, Huo B, Hao Y, Cheng X, Xie T, Cheng Q, Zhou T, Zhou L, Chen S, Zhou Y, Chen J.   +12 more
europepmc   +1 more source

强化免疫抑制治疗儿童再生障碍性贫血疗效分析

Zhongshan Daxue xuebao. Yixue kexue ban, 2004
【目的】探讨强化免疫抑制治疗儿童再生障碍性贫血的疗效及毒副作用的防治。【方法】总结我科1996—2003年儿童再障32例,均采用强化免疫抑制治疗(IIST),根据免疫抑制药物的不同组合分为2组:4种药物联合组和2～3种药物联合组。【结果】总有效率为71.88%,4种药物联合组、2～3种药物联合组有效率分别为72.2%及71.33%,差别无显著性。治疗过程中,致命的合并症为败血症,尤其潜伏病毒激活及深部真菌感染。随访中没有病例发展为阵发性睡眠性血红蛋白尿(PNH),骨髓异常增生综合征(MDS ...
doaj  

Predictive value of NUF2 for prognosis and immunotherapy responses in pan-cancer. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Y, Chen L, Luo Y, Shen J, Zhou S.
europepmc   +1 more source

[Advances in Immunotherapy of KRAS-mutated Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Yang X, Tang Z, Ma L, Chen R.
europepmc   +1 more source

[Construction of a prognosis forecasting model for immuno-therapy response in cancer patients by integrating routine clinical parameters and tumor mutational burden]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhu X, Hao S, Cheng Z, Fang W.
europepmc   +1 more source

[Advances in Radiotherapy for Extensive-stage Small Cell Lung Cancer 
in the Era of Immunotherapy]. [PDF]

Zhongguo Fei Ai Za Zhi
Chen T, Yang Y, Han H, Liu D, Yuan Y, Xu L.   +5 more
europepmc   +1 more source